OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform


c Categories
p Projects
  • Highlighted
  • Trial protocol
  • Study Design
  • RCT
  • Cluster RCT
  • Observational
  • Model
  • Meta-analysis
  • Review
  • Guideline
  • Outcomes
  • Change patient management
  • Clinical outcomes
  • Economics
  • Operational efficiencies
  • Patient-centeredness
  • Safety
  • Guide Policy Making
  • Other
  • Uncategorized
  • Antibiotic Guidance
  • ACT Guided Heparinization
  • Cancer
  • COVID-19
  • Cardiovascular Disease
  • Diabetes
  • HIV POCT
  • Inflammatory Bowel Disease
  • Liver Disease
  • Kidney Disease
  • Newborn Screening
  • MALDI-TOF MS For Microorganism Identification
  • Preeclampsia
  • Pharmacogenetic and Pharmacogenomics
  • Therapeutic drug monitoring
  • Viscoelastic Testing

Please contact us for any suggestions



Zhen Zhao



Smeralda Skenderaj

Project:Cancer
Categories:ObservationalEconomics
5 Publications found
  • From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for -Positive Non-Small Cell Lung Cancer (MOST Study).

    b
    The oncologist
    June 1, 2019
    p Cancer
    c Change patient management Economics Observational
  • Effect of a Collaboration Between a Health Plan, Oncology Practice, and Comprehensive Genomic Profiling Company from the Payer Perspective.

    b
    Journal of managed care & specialty pharmacy
    May 1, 2019
    p Cancer
    c Economics Observational
  • Estimated Cost of Anticancer Therapy Directed by Comprehensive Genomic Profiling in a Single-Center Study.

    b
    JCO precision oncology
    January 1, 2018
    p Cancer
    c Change patient management Clinical outcomes Economics Observational
  • The cost of molecular-guided therapy in oncology: a prospective cost study alongside the MOSCATO trial.

    b
    Genetics in medicine : official journal of the American College of Medical Genetics
    June 1, 2017
    p Cancer
    c Economics Observational
  • A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer Reveals Improved Progression-Free Survival Without Increased Health Care Costs.

    b
    Journal of oncology practice
    February 1, 2017
    p Cancer
    c Change patient management Clinical outcomes Economics Highlighted Observational